How the global shift in health innovation redefines the role of industrial policies and exposes the backwardness of Brazil's strategy The pharmaceutical industry is experiencing a historic shift. The model that, for half a century, concentrated drug discovery in large, integrated corporations is fragmenting. Vertical integration, a symbol of strength in the 20th century, has given way to a decentralized network of small biotechs , academic laboratories, and deep tech startup

In recent years, Brazil has faced a persistent paradox: it produces ever-increasing amounts of science, but continues to transform little...

How to revive the cooperative model that can transform Brazil into a biotechnology powerhouse When I received the invitation in 2005 to...

The global pharmaceutical and biotechnology industry is experiencing a period of accelerated growth in drug use and spending, driven by...

The emergence of cutting-edge technologies, known as deeptechs, marks a new phase in global innovation. These technologies, which emerge...

In recent years, I’ve had the privilege of closely following the birth and growth of dozens of health startups, both in Brazil and...

Throughout my career as an executive, consultant, and entrepreneur in healthcare, I have always sought to connect science, innovation,...

Technological innovation is a fundamental factor for a country’s economic development and competitiveness. In Brazil, intellectual...

In the contemporary global landscape, the concept of an isolated national economy has become a fiction. Nations do not compete solely for...

Brazil’s biodiversity, widely recognized as one of the richest in the world, offers a window of opportunity for innovative health...

The global Alzheimer’s market is undergoing a significant transformation. According to GlobalData , this market is expected to reach...